Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(42 sites)
United States
City of Hope, Duarte, California City of Hope, Huntington Beach, California City of Hope, Irvine, California City of Hope, Long Beach, California University of California, San Francisco, San Francisco, California